LU82026A1 - Preparation pharmaceutique comprenant un glycoside cardiaque ayant un revetement de polymere - Google Patents

Preparation pharmaceutique comprenant un glycoside cardiaque ayant un revetement de polymere Download PDF

Info

Publication number
LU82026A1
LU82026A1 LU82026A LU82026A LU82026A1 LU 82026 A1 LU82026 A1 LU 82026A1 LU 82026 A LU82026 A LU 82026A LU 82026 A LU82026 A LU 82026A LU 82026 A1 LU82026 A1 LU 82026A1
Authority
LU
Luxembourg
Prior art keywords
layer
pharmaceutical preparation
cardiac glycoside
soluble
solution
Prior art date
Application number
LU82026A
Other languages
English (en)
French (fr)
Inventor
C Appelgren
C Bogentoft
J Sjoegren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of LU82026A1 publication Critical patent/LU82026A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
LU82026A 1978-12-22 1979-12-21 Preparation pharmaceutique comprenant un glycoside cardiaque ayant un revetement de polymere LU82026A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE7813246A SE7813246L (sv) 1978-12-22 1978-12-22 Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
SE7813246 1978-12-22

Publications (1)

Publication Number Publication Date
LU82026A1 true LU82026A1 (fr) 1980-07-21

Family

ID=20336689

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82026A LU82026A1 (fr) 1978-12-22 1979-12-21 Preparation pharmaceutique comprenant un glycoside cardiaque ayant un revetement de polymere

Country Status (20)

Country Link
US (1) US4263273A (sv)
EP (1) EP0013262B1 (sv)
JP (1) JPS5587716A (sv)
AT (1) ATE4370T1 (sv)
AU (1) AU531280B2 (sv)
BE (1) BE880797A (sv)
CA (1) CA1130211A (sv)
CH (1) CH641357A5 (sv)
DE (1) DE2966036D1 (sv)
DK (1) DK542279A (sv)
ES (1) ES487181A0 (sv)
FI (1) FI794007A (sv)
GR (1) GR69819B (sv)
IE (1) IE48891B1 (sv)
LU (1) LU82026A1 (sv)
NO (1) NO152726C (sv)
NZ (1) NZ192441A (sv)
PT (1) PT70619A (sv)
SE (1) SE7813246L (sv)
ZA (1) ZA796684B (sv)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
ATE14379T1 (de) * 1981-04-27 1985-08-15 Haessle Ab Pharmazeutisches praeparat.
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
IE56459B1 (en) * 1983-12-21 1991-08-14 Elan Corp Ltd Controlled absorption pharmaceutical formulation
US4894240A (en) * 1983-12-22 1990-01-16 Elan Corporation Plc Controlled absorption diltiazem formulation for once-daily administration
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
JPH0759499B2 (ja) * 1984-02-10 1995-06-28 ベンツォン ファーマ エイ／エス 拡散被覆された複合単位服用剤
GB8414220D0 (en) * 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
US4656831A (en) * 1985-05-14 1987-04-14 Chamberlain Manufacturing Corporation Apparatus and method of recovering water from engine exhaust gases
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US4883666A (en) * 1987-04-29 1989-11-28 Massachusetts Institute Of Technology Controlled drug delivery system for treatment of neural disorders
US5601835A (en) * 1987-04-29 1997-02-11 Massachusetts Institute Of Technology Polymeric device for controlled drug delivery to the CNS
US5912017A (en) * 1987-05-01 1999-06-15 Massachusetts Institute Of Technology Multiwall polymeric microspheres
US5985354A (en) 1995-06-07 1999-11-16 Brown University Research Foundation Preparation of multiwall polymeric microcapsules from hydrophilic polymers
JPH0774151B2 (ja) * 1987-10-12 1995-08-09 三井東圧化学株式会社 薬物の好ましくない官能的性質を隠蔽した散剤の製造方法
JPH01165520A (ja) * 1987-12-23 1989-06-29 Shin Etsu Chem Co Ltd 持続性製剤およびその製造方法
US4925675A (en) * 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US4966770A (en) * 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
FR2663222A1 (fr) * 1990-06-13 1991-12-20 Medgenix Group Sa Microcapsule de liquide huileux.
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5167964A (en) * 1992-02-14 1992-12-01 Warner-Lambert Company Semi-enteric drug delivery systems and methods for preparing same
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US20040082521A1 (en) * 2002-03-29 2004-04-29 Azaya Therapeutics Inc. Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2455790A (en) * 1945-06-09 1948-12-07 Eastman Kodak Co Enteric coatings
CH283585A (de) * 1950-03-15 1952-06-15 Hoffmann La Roche Zur Herstellung von Tablettenüberzügen geeignetes Gemisch.
US2698822A (en) * 1951-04-28 1955-01-04 Fougera & Co Inc E Cardiac glycoside buccal composition
US2881085A (en) * 1953-11-09 1959-04-07 Abbott Lab Thin film coating for tablets and the like
US2853420A (en) * 1956-01-25 1958-09-23 Lowey Hans Ethyl cellulose coatings for shaped medicinal preparations
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
NO98434A (sv) * 1959-04-30
NL270408A (sv) * 1960-10-20
DE1228757B (de) * 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3325365A (en) * 1963-04-02 1967-06-13 Ciba Geigy Corp Enteric composition for tablet compression coating
NL297631A (sv) * 1963-06-03
US3400185A (en) * 1965-04-08 1968-09-03 Bristol Myers Co Agglomeration of smaller pharmaceutical particles into larger microspherules and enteic-coating thereof
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US3954959A (en) * 1973-03-28 1976-05-04 A/S Alfred Benzon Oral drug preparations
IL42166A (en) * 1973-05-02 1976-01-30 Res Prod Rehovot Ltd Drug releasing preparation
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US3965255A (en) * 1974-05-01 1976-06-22 E. E. Eljim Ecology Ltd. Controlled drug releasing preparations
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
SE418247B (sv) 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
US4147768A (en) * 1976-09-13 1979-04-03 Interx Research Corporation Enteric coated digoxin and therapeutic use thereof

Also Published As

Publication number Publication date
NO794252L (no) 1980-06-24
NO152726B (no) 1985-08-05
PT70619A (en) 1980-01-01
DK542279A (da) 1980-06-23
ES8101887A1 (es) 1980-12-16
CH641357A5 (de) 1984-02-29
AU531280B2 (en) 1983-08-18
EP0013262A3 (en) 1981-05-27
AU5396379A (en) 1980-06-26
IE48891B1 (en) 1985-06-12
EP0013262A2 (en) 1980-07-09
FI794007A (fi) 1980-06-23
ZA796684B (en) 1980-11-26
NZ192441A (en) 1984-05-31
BE880797A (fr) 1980-06-23
DE2966036D1 (en) 1983-09-08
ES487181A0 (es) 1980-12-16
JPS5587716A (en) 1980-07-02
SE7813246L (sv) 1980-06-23
CA1130211A (en) 1982-08-24
EP0013262B1 (en) 1983-08-03
IE792454L (en) 1980-06-22
GR69819B (sv) 1982-07-13
NO152726C (no) 1985-11-13
ATE4370T1 (de) 1983-08-15
US4263273A (en) 1981-04-21

Similar Documents

Publication Publication Date Title
LU82026A1 (fr) Preparation pharmaceutique comprenant un glycoside cardiaque ayant un revetement de polymere
EP0624371B1 (fr) Microcapsules pour la libération contrôlée d'acide acétylsalicylique
EP2349227B1 (fr) Forme pharmaceutique orale a base de microgranules a liberation prolongee resistante a l'alcool
LU82025A1 (fr) Preparation pharmaceutique comprenant un glycoside cardiaque en combinaison avec un polymere
CA2606887C (fr) Composition pharmaceutique
FR2630912A1 (fr) Composition permettant d'administrer un medicament sous forme de gelules, d'une poudre ou d'un liquide
FR2629716A1 (fr) Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
FR2613619A1 (fr) Medicaments, produits dietetiques ou produits d'hygiene sous forme de compositions pulverulentes obtenues par adsorption de principes actifs sur un sucre a dissolution rapide
WO2012022919A2 (fr) Formulations à base de nalbuphine et leurs utilisations
FR2930147A1 (fr) Forme orale solide dotee d'un double profil de liberation
JPS635020A (ja) 制御放出性イブプロフエン製剤
WO2005004860A2 (fr) Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
BE897221A (fr) Produits a effet prolonge contenant du suloctidil
FR2542194A1 (fr) Preparations pharmaceutiques a base de rifampicine ayant des proprietes d'elution uniformes
FR2467596A1 (fr) Compositions pharmaceutiques de tiaramide ou de son sel et d'un agent reglant la dissolution, a longue duree d'action
CH665637A5 (fr) 5-(3-n-butyloxalylaminophenyl)tetrazole comme agent antiasthmatique, composition le contenant et procede de preparation de la composition.
WO2009153447A1 (fr) Forme galenique orale, procede de fabrication du polymere et utilisation
WO2023194433A1 (fr) Composition pharmaceutique à base de vorapaxar et son utilisation pour le traitement des maladies inflammatoires intestinales
LU87777A1 (fr) Nouvelle forme galenique orale ameliorant la biodisponibilite
CA2459176A1 (fr) Composition orale comprenant un extrait d'ecorce d'albizzia myriophylla
EP4313155A1 (fr) Formulation par voie orale d'ivermectine et utilisations
WO2022175470A1 (fr) Composition pour renforcer le systeme immunitaire
FR2715067A1 (fr) Nouvelle forme galénique de dérivés de 5-nitro-imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus gastro-intestinal.
FR2656303A1 (fr) Solution buvable d'un derive des benzodiazepines et son application pharmacologique.
FR3013986A1 (fr) Composition pharmaceutique ou dietetique contenant l'extrait de semence d'avena sativa et utilisable pour soigner le syndrome metabolique